New research may indicate a potential advantage of buprenorphine use for opioid-use disorder (OUD) during pregnancy instead of methadone.
New Brunswick, New Jersey — Led by Elizabeth A. Suarez, PhD, MPH, from the Rutgers Institute for Health, Health Care Policy and Aging Research, new research may indicate a potential advantage of buprenorphine use for opioid-use disorder (OUD) during pregnancy instead of methadone. Maternal and neonatal outcomes were investigated among a cohort of pregnant women, with lower infant-related risks seen in connection with buprenorphine use.
Buprenorphine has already been shown to be of potential use for individuals soon to initiate treatment for OUD, and the current research utilized Medicaid data on such maternal-related outcomes as cesarean delivery and pregnancy complications and such infant-related outcomes as neonatal abstinence syndrome and low birth weight.
“It’s essential for the general public to understand the importance of OUD treatment during pregnancy to avoid harms associated with lack of treatment,” Suarez noted. “These results may guide clinical recommendations for people with OUD who are pregnant or are hoping to be pregnant.”
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
2 Clarke Drive
Cranbury, NJ 08512